Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received formal ...
Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
EN1d
RX UK signs up to Hidden Disabilities Sunflower scheme
RX UK has become a member of the Hidden Disabilities Sunflower network, reinforcing its commitment to creating a fully ...
TopSpeed6d
10 Cars That Earned A Peculiar Reputation
Over the years, certain models have gained peculiar reputations, making them the subjects of both ridicule and fascination ...